BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31982989)

  • 1. Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders.
    Borja AJ; Hancin EC; Zhang V; Revheim ME; Alavi A
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2493-2498. PubMed ID: 31982989
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-deoxy-fluorglucose-positron emission tomography imaging of the brain: current clinical applications with emphasis on the dementias.
    Van Heertum RL; Greenstein EA; Tikofsky RS
    Semin Nucl Med; 2004 Oct; 34(4):300-12. PubMed ID: 15493007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT of Dementia.
    Zukotynski K; Kuo PH; Mikulis D; Rosa-Neto P; Strafella AP; Subramaniam RM; Black SE
    AJR Am J Roentgenol; 2018 Aug; 211(2):246-259. PubMed ID: 29949415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography.
    Lameka K; Farwell MD; Ichise M
    Handb Clin Neurol; 2016; 135():209-227. PubMed ID: 27432667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positron emission tomographic studies using C-11-glucose in normal aging and cerebrovascular dementia].
    Ujike T; Terashi A; Soeda T; Kitamura S; Kato T; Iio M
    No To Shinkei; 1984 Jun; 36(6):559-66. PubMed ID: 6331840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage dementia: Comparison of arterial spin labelling MRI and FDG PET-CT in suspected dementia.
    Weyts K; Vernooij M; Steketee R; Valkema R; Smits M
    Clin Imaging; 2017; 45():1-7. PubMed ID: 28551486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Grassetto G; Marzola MC; Musto A; Viniamury S; Colletti PM; Perkins AC; Rubello D
    Nucl Med Commun; 2014 Nov; 35(11):1085-92. PubMed ID: 25162962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Occipital Tunnel" Sign on FDG PET for Differentiating Dementias.
    Sawyer DM; Kuo PH
    Clin Nucl Med; 2018 Feb; 43(2):e59-e61. PubMed ID: 29232244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
    Sawyer DM; Kuo PH
    Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of
    Sarikaya I; Sarikaya A; Elgazzar AH
    J Nucl Med Technol; 2018 Dec; 46(4):362-367. PubMed ID: 30076253
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete splenic vein tumour thrombus in primary gastric malignancy on F18-fluorodeoxyglucose positron emission tomography-computed tomography.
    Ahmad W; Asghar N; Zafar T; Bashir H
    J Pak Med Assoc; 2021 Jan; 71(1(A)):175-176. PubMed ID: 33484552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on "Comparison of CT and PET/CT for biopsy guidance in oncological patients".
    Chen L; Sun H
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):151. PubMed ID: 28808744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.